

Learn about Insulin Degludec (Tresiba) side effects, from common reactions to serious warnings. Know when to call your doctor.
Every medication comes with potential side effects, and Insulin Degludec (brand name Tresiba) is no exception. The good news is that most people tolerate this ultra-long-acting basal insulin well. But it's important to know what's normal, what's not, and when you should call your doctor.
This guide covers the common and serious side effects of Insulin Degludec based on FDA labeling, plus practical tips for managing them.
Insulin Degludec is an ultra-long-acting basal insulin made by Novo Nordisk. It's FDA-approved for type 1 diabetes (adults and children age 1+) and type 2 diabetes (adults). It works by forming a depot under the skin that slowly releases insulin over 42+ hours, giving you a flat, stable glucose-lowering effect with less day-to-day variability than many other basal insulins.
For more details on how it works, see our guide on Insulin Degludec's mechanism of action.
These side effects are reported frequently in clinical trials and are usually mild to moderate:
These are less common but require immediate medical attention:
Insulin Degludec is approved for children age 1 and older with type 1 diabetes. Side effects are similar to adults, with hypoglycemia being the primary concern. Children may have difficulty recognizing or communicating low blood sugar symptoms, so parents and caregivers should monitor closely.
No dose adjustment is needed for older adults, but they may be more vulnerable to hypoglycemia and its consequences (falls, confusion). Careful glucose monitoring is recommended.
There's limited data on Insulin Degludec in pregnancy. Your doctor will weigh the benefits and risks. Insulin is a natural hormone, and exogenous insulin is unlikely to harm a breastfed infant, but discuss it with your provider.
No dose adjustment is required, but insulin clearance may be reduced in people with kidney or liver impairment. Your doctor may ask you to monitor blood sugar more frequently.
Contact your healthcare provider if you experience:
Most people do well on Insulin Degludec (Tresiba), and its ultra-long duration means more stable blood sugar with fewer spikes and crashes compared to some other basal insulins. Side effects are generally manageable, and the most important one to watch for — hypoglycemia — can be minimized with proper dosing and monitoring.
If you're having trouble finding Tresiba in stock, Medfinder can help you locate pharmacies near you that have it available. And if cost is a concern, check out our guide to saving money on Insulin Degludec.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.